Cue Health Reports Fourth Quarter and Full-Year 2022 Financial Results

SAN DIEGO–(BUSINESS WIRE)–Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the fourth quarter and full-year 2022. Recent and Full-Year 2022 Highlights Reported fourth quarter revenue of $146.8 million, including $92.4 million in deferred revenue related to our agreement with the U.S. Department of Defense. Full-year 2022 revenue was … [Read more…]

ADC Therapeutics Releases its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2022

LAUSANNE, Switzerland–(BUSINESS WIRE)–ADC Therapeutics SA (NYSE: ADCT) today announced its Annual Report on Form 20-F for the fiscal year ended December 31, 2022, has been filed with the U.S. Securities and Exchange Commission (the “SEC”). ADC Therapeutics’ Annual Report on Form 20-F can be accessed by visiting either the SEC’s website at www.sec.gov or the … [Read more…]

Hims & Hers Announces New Anti-Dandruff Shampoo for Hims Customers

SAN FRANCISCO–(BUSINESS WIRE)–Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, is today announcing Hims Dandruff Detox, a unique shampoo formulated with doctors that both fights dandruff and supports scalp health. This powerful and gently-cleansing formula was developed with doctors to be vegan, cruelty-free and free of parabens, … [Read more…]

Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature

The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans Findings support further clinical development for prevention and treatment of dengue, which impacts millions of people today and is poised to threaten many more due to climate change Research builds on Johnson & Johnson’s enduring commitment to beat neglected tropical diseases, … [Read more…]

MassInnovation Network Announces the 2023 Global Eddies Cohort

LINCOLN, Mass.–(BUSINESS WIRE)–#innovation–The presentations of the 2023 Global Innovation Cohort will take place on Thursday March 23, 9 am. The cohort comprises: Boston Cryogenics: next-generation patent-pending cryogenic cooling technologies for cooling quantum computers, superconducting magnets, cryogenic detectors and sensors, etc. The technologies -mainly focusing on pulse tube (PT) cryocoolers- incorporate higher efficiency, higher cooling capacity, … [Read more…]

Inspire Biotherapeutics Launches with Pre-seed Investment to Target Monogenic and Acquired Lung Diseases with Proprietary AAVenger Gene Therapy Platform

The AAVenger platform has demonstrated superior lung tropism and transduction efficiency of cells in the upper and lower respiratory tract of the lung, rapid and sustained expression of therapeutic transgenes, and is amenable to repeat dosing. Inspire’s Business Founders – C3i Center Inc, Octane Medical Group of Companies, and Ontario Institute for Regenerative Medicine – … [Read more…]

Wavemaker Three-Sixty Health Announces 2023 Council of Strategic Advisors to Support the Fund in Transforming U.S. Healthcare

LOS ANGELES–(BUSINESS WIRE)–Wavemaker Three-Sixty Health (Wavemaker 360), the nation’s leading venture fund focused singularly on early-stage (primarily seed) healthcare disruptors, is continuing its mission for healthcare innovation with the announcement of its 2023 Council of Strategic Advisors. Comprised of a distinguished and diverse group of healthcare leaders representing different parts of the U.S. healthcare system, … [Read more…]

Checkerspot’s Pollinator™ Kit for Renewable Design wins SXSW Innovation Award in the Design Category

The Pollinator™ Kit makes new biobased materials accessible to designers, creators, and innovators of all skill levels ALAMEDA, Calif. & SALT LAKE CITY–(BUSINESS WIRE)–Checkerspot, Inc., a biotechnology company with an award-winning design and innovation lab, announced today that its Pollinator™ Kit for Renewable Design won the distinguished SXSW Innovation Award in the Design category. The … [Read more…]

IPS Strengthens Biologics Expertise with New Team Members, Brian Horowski and Bob Forbes

BLUE BELL, Pa.–(BUSINESS WIRE)–IPS-Integrated Project Services, LLC, a leading provider of engineering, procurement, construction management, and validation (EPCMV) services, announces the appointment of two industry-leading professionals to support the company’s continued growth in forefront biologics and other 21st-century therapeutics. Brian Horowski joins IPS as Director of Process Architecture, and Bob Forbes, PE, as a Senior … [Read more…]